---
figid: PMC9878249__MEF2-1-0-g006
pmcid: PMC9878249
image_filename: MEF2-1-0-g006.jpg
figure_link: /pmc/articles/PMC9878249/figure/mef229-fig-0004/
number: Figure 4
figure_title: ''
caption: The function of SARS‐CoV‐2 structural proteins on RIG‐I‐MAVS signaling pathway.
  (A) SARS‐CoV‐2 M impedes the formation of RIG‐I ‐MAVS signaling pathway. (B) SARS‐CoV‐2
  N protein inhibits RIG‐I‐MAVS signaling pathway by targeting G3BP1 and PACT. MAVS,
  mitochondrial antiviral signaling; RIG‐I, retinoic acid‐inducible gene I.
article_title: 'SARS‐CoV‐2 modulation of RIG‐I‐MAVS signaling: Potential mechanisms
  of impairment on host antiviral immunity and therapeutic approaches.'
citation: Mingming Wang, et al. 2022 Sep;1(2):e29.
year: '2022'

doi: 10.1002/mef2.29
journal_title: MedComm – Future Medicine
journal_nlm_ta: ''
publisher_name: John Wiley and Sons Inc.

keywords:
- antiviral immunity
- RIG‐I‐MAVS signaling
- SARS‐CoV‐2
- therapeutic approaches

---
